Questionable effectiveness of the QuantiFERON-TB gold test (cellestis) as a screening tool in healthcare workers

Infection Control and Hospital Epidemiology

Volumn 31, Issue 12, 2010, Pages 1279-1285

  Gandra, Sumanth ^a   Scott, William S ^a   Somaraju, Vijaya ^a   Wang, Huaping ^a   Wilton, Suzanne ^b   Feigenbaum, Michelle ^b  

^a UNIVERSITY OF ILLINOIS   (United States)

^b OSF SAINT FRANCIS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DIAGNOSTIC ACCURACY; FEMALE; HEALTH CARE PERSONNEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; RETROSPECTIVE STUDY; SCREENING TEST; TUBERCULIN TEST; TUBERCULOSIS;

ADULT; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH PERSONNEL; HEMATOLOGIC TESTS; HUMANS; ILLINOIS; INTERFERON-GAMMA; LATENT TUBERCULOSIS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; OCCUPATIONAL DISEASES; POPULATION SURVEILLANCE; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; UNITED STATES;

EID: 78649912205     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/657336     Document Type: Article

References (13)

1. Menzies D. What does tuberculin reactivity after Bacille Calmette-Guerin vaccination tell us? Clin Infect Dis 2000;31(suppl 3):S71-S74.
2. Andersen P, Munk ME, Pollock JM, Doherty TM. Specific immune-based diagnosis of tuberculosis. Lancet 2000;356(9235):1099-1104.
3. Centers for Disease Control and Prevention. Tuberculosis (TB). September 29, 2010. http://www.cdc.gov/tb/publications/factsheets/testing/QFT.htm/. Accessed January 29, 2010.
4. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007;146(5):340-354.
5. Mazurek GH, Jereb J, LoBue P, Iademarco MF, Metchock B, Vernon A; Division of Tuberculosis Elimination, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC). Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 2005;54(RR-15):49-55.
6. Nienhaus A, Schablon A, Le Bâcle C, Siano B, Diel R . Evaluation of the interferon-γ release assay in healthcare workers. Int Arch Occup Environ Health 2008;81:295-300.
7. Harada N, Nakajima Y, Higuchi K, Sekiya Y, Rothel J, Mori T. Screening for tuberculosis infection using whole blood interferon γ and Mantoux testing among Japanese healthcare workers. Infect Control Hosp Epidemiol 2006;27:442-448. (Pubitemid 43835524)
8. Pollock NR, Campos-Neto A, Kashino S, et al. Discordant Quantiferon-TB Gold test results among US healthcare workers with increased risk of latent tuberculosis infection: a problem or solution? Infect Control Hosp Epidemiol 2008;29(9):878-886.
9. Diagnosis of Tuberculosis Infection and Disease. Canadian tuberculosis standards. 6th ed. 2007:83-84.
10. Perry S, Sanchez L, Yang S, Agarwal Z, Hurst P, Parsonnet P. Reproducibility of QuantiFERON-TB Gold In-Tube assay. Clin Vaccine Immunol 2008;15(3):425-432. (Pubitemid 351967072)
11. Pai M, O'Brien R. Serial testing for tuberculosis: can we make sense of T cell assay conversions and reversions? PLoS Med 2007;4(6):e208.
12. de Perio MA, Tsevat J, Roselle GA, Kralovic SM, Eckman MH. Cost-effectiveness of interferon gamma release assays vs. tuberculin skin tests in health care workers. Arch Intern Med 2009;169(2):179-187.
13. Oxlade O, Schwartzman K, Menzies D. Interferon-gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis. Int J Tuberc Lung Dis 2007;11:16-26.